Rare Diseases
What This Page Covers
This page collects the 8 public records POLISCOPE has tagged with “Rare Diseases”. Coverage spans bills and news coverage - each decoded into plain English and linked to its primary source. It most often overlaps with Healthcare, Medical Research, and Healthcare Policy.
Active Bills
Recent Activity
Finance Signals
No finance signals found for this topic in the available records yet.
Open the Money page to search by entity, donor, or PAC.
Reported financial relationships and timing signals. This does not prove motive or influence.
Key Actors
- 01Food and Drug Administrationorganization2 mentions
- 02Secretaryorganization1 mentions
- 03Hawleyperson1 mentions
- 04n-Lorem Foundationorganization1 mentions
- 05Padillaperson1 mentions
- 06Carlsbadlocation1 mentions
- 07Schmittperson1 mentions
- 08Rand Paulperson1 mentions
- 09Homeland Securityorganization1 mentions
- 10IntraBio, Inc.organization1 mentions
Connections Preview
Lightweight relationship summary. Open the full graph for the interactive view, including 1-hop neighbours and money edges.
- Topic to billsAccelerating Access to Critical Therapies for ALS Reauthorization Act of 2026, Indiana House of Representatives recognizes May 2026 as Myositis Awareness Month, Genomic Answers for Children’s Health Act of 2026 (+1 more)
- Topic to peopleHawley, Padilla, Schmitt (+1 more)
- Topic to orgsFood and Drug Administration, Secretary, n-Lorem Foundation (+2 more)
Source Trail
Documents whose extracted record lists this topic. Each item opens the Bill Dossier, which includes the official source URL when available.
- Aug 11, 2026Newsn-Lorem Foundation and BioMarin Pharmaceutical partner to develop ReNU syndrome treatment
- Apr 6, 2026Federal BillAccelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
- Feb 18, 2026State BillIndiana House of Representatives recognizes May 2026 as Myositis Awareness Month
- Jan 15, 2026Federal BillGenomic Answers for Children’s Health Act of 2026
- May 23, 2024Federal BillPromising Pathway Act 2.0: New Conditional Approval Process for Rare Disease Drugs
- Jan 1, 2020hearing transcriptSenate Hearing: Speeding Up Treatments for Rare Diseases
Showing 6 of 8 source records.
